InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: Scotttrader80 post# 78724

Monday, 05/04/2020 8:40:25 AM

Monday, May 04, 2020 8:40:25 AM

Post# of 97093

check out this companys response concerning CV19

Quote:
Adjustment disorder is an emotional or behavioral reaction considered excessive or out of proportion to a stressful event or major life change, occurring within three months of the stressor, and/or significantly impairing a person's social, occupational and/or other important areas of functioning. VistaGen has announced plans to expand clinical development of PH94B to include treatment of adjustment disorder due to stressors related to the COVID-19 pandemic. Learn more here:
Download as PDF April 28, 2020 Proposed Phase 2 Study to Take Place in New York City Under U.S. FDA's Coronavirus Treatment Acceleration Program (CTAP) SOUTH SAN FRANCISCO, Calif., April 28, 2020 /PRNewswire/ -- VistaGen Therapeutics a clinical-stage biopharmaceutical company develop...





I saw that, it is interesting but not what DECN is doing.

DECN is attempting to DIAGNOSE COVID 19 - I dont think DECN has to worry about a drug that the FDA gave fast track and needed drug status as competition.